COMPOSITION FOR TREATING HYPERLIPIDEMIA CONTAINING AN OXYNTOMODULIN DERIVATIVE Russian patent published in 2022 - IPC C07K14/605 C07K19/00 A61K38/26 A61K47/68 A61P3/06 

Abstract RU 2768853 C1

FIELD: biotechnology.

SUBSTANCE: present invention relates to compositions based on a conjugate of an oxyntomodulin derivative, and can be used in medicine to reduce blood lipids in preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis. Oxyntomodulin derivative with SEQ ID NO: 28, 32–34, fused with Fc-region of immunoglobulin through non-peptidyl polymer, which covalently binds derivative of oxyntomodulin and Fc-region of immunoglobulin.

EFFECT: invention enables to obtain a conjugate of an oxyntomodulin derivative, having high ability to activate GLP-1 receptor and glucagon receptor in comparison with natural oxyntomodulin and allowing to effectively reduce the levels of total cholesterol, low-density cholesterol and triglycerides in the blood, which were increased due to a high-fat diet, and increase high-density cholesterol levels and high-density/low-density cholesterol ratio.

16 cl, 10 dwg, 3 tbl, 6 ex

Similar patents RU2768853C1

Title Year Author Number
CONJUGATE CONTAINING OXINTOMODULIN AND IMMUNOGLOBULIN FRAGMENT, AND ITS APPLICATION 2012
  • Jung Sung Youb
  • Kim Dae Jin
  • Park Sung Hee
  • Woo Young Eun
  • Choi In Young
  • Kwon Se Chang
RU2733544C2
PHARMACEUTICAL COMPOSITION CONTAINING INSULIN AND GLUCAGON 2019
  • Kim Jung Kuk
  • Lee Jong Suk
  • Dong Joo Young
  • Lee A Ram
RU2823246C2
NOVEL OXYNTOMODULIN DERIVATIVES AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM FOR TREATING OBESITY 2012
  • Jung Sung Youb
  • Jang Myung Hyun
  • Shen Ling Ai
  • Park Young Kyung
  • Park Young Jin
  • Kwon Se Chang
RU2739209C2
FULLY HUMAN MESOTHELIN ANTIBODIES AND IMMUNE EFFECTOR CELLS TARGETING MESOTHELIN 2016
  • Wang Huamao
  • Song Bo
  • Wang Peng
RU2748281C2
ANTIBODIES AGAINST CD79b, DRUG CONJUGATES AND THEIR USE 2019
  • Han Nianhe
  • Song Liwei
  • An Deqiang
  • Zeng Di
  • Li Huali
  • Yang Chun
RU2805251C2
NOVEL PROTEIN CONJUGATE AND USE THEREOF FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETES 2021
  • Kim, Yunki
  • Kim, Minsun
  • Kim, Ryuryun
  • Choi, Jaeyoung
  • Yim, Yeseal
  • Shim, Myungbo
  • Han, Daye
  • Im, Daeseong
  • Park, Sungjin
RU2822001C1
GLYPICAN-3 ANTIBODY AND USE THEREOF 2016
  • Wang Huamao
  • Song Bo
RU2744245C2
FGF21 FUSED WITH LONG-ACTING PROTEINS AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 2016
  • Kim, Jun Hwan
  • Lim, Seyoung
  • Seo, Minji
  • Choi, Hyun Ho
  • Kim, Dohoon
  • Ju, Mi Kyeong
  • Park, Ju-Young
  • Choi, Byung Hyun
  • Lee, Jun Kyung
  • Kim, Jong Gyun
  • Nam, Su Youn
RU2741087C2
LONG-ACTING DOUBLE AGONIST OF GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON RECEPTORS 2021
  • Yan, Che-Son
  • Li, Kyun-Sok
  • Chkhe, Yu-Na
  • Kim, Te-Khyun
  • Chon, Ill-Khun
  • Lyu, Chkhe-Lim
  • Li, Tkhe-Yun
RU2799327C1
IMPROVED FACTOR IX FUNCTION PROTEIN AND ITS CONJUGATE AND THEIR USE 2020
  • Su Hongsheng
  • Chen Xian
  • Mo Weichuan
  • Zhu Luyan
  • Yan Haixia
  • Ren Zijia
  • Wang Yali
RU2794350C1

RU 2 768 853 C1

Authors

Jung Sung Youb

Kim Jin-Sun

Jang Myung Hyun

Lee Sang Hyun

Choi In Young

Kwon Se Chang

Dates

2022-03-25Published

2013-07-25Filed